Radiological Arm
ProcedureClinical Visit + X-Ray Chest
NCT Number: NCT00198341
The follow-up of patients operated on for lung cancer is heterogeneous. An intensive follow-up including routine clinic visits, chest X-rays, chest computed tomography (CT) scans and fiberoptic bronchoscopies might detect more small, potentially curable, recurrences and second cancers. However, as it appears in the American Society of Clinical Oncology (ASCO) recommendations, a large randomized study is necessary to evaluate the survival impact of such a follow-up strategy. This is the main objective of this IFCT-0302 study, which is a large randomized controlled study conducted in France comparing this intensive follow-up to a follow-up with only routine clinic visits and chest X-rays.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Centre Hospitalier - Pneumologie, Belfort, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical Visit + X-Ray Chest
Clinical visit + X-Ray Chest + CT-Scan + Fibroscopy (for squamous cell)
Time frame: 6-month
Intergroupe Francophone de Cancerologie Thoracique
Other
Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04738487
Bronchial Neoplasms, Carcinoma, Bronchogenic
Boca Raton, Florida, United States
View Trial DetailsNCT03088540
Bronchial Neoplasms, Carcinoma, Bronchogenic
Albury, New South Wales, Australia
View Trial DetailsNCT01421953
Bronchial Neoplasms, Carcinoma, Bronchogenic
Bordeaux, France
View Trial DetailsNCT02578680
Bronchial Neoplasms, Carcinoma, Bronchogenic
View Trial Details